BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27600434)

  • 1. An appeal for the integrity of science and public policy.
    Toxicology; 2016 Sep; 371():1-11. PubMed ID: 27600434
    [No Abstract]   [Full Text] [Related]  

  • 2. Deepening uncertainty on how the EU may regulate supposable endocrine disruptors.
    Gori GB; Dekant W
    Regul Toxicol Pharmacol; 2016 Nov; 81():8-9. PubMed ID: 27350054
    [No Abstract]   [Full Text] [Related]  

  • 3. Financial conflicts of interest in the National Institutes of Health?
    Maloney DM
    Hum Res Rep; 2004 Mar; 19(3):1-3. PubMed ID: 15139341
    [No Abstract]   [Full Text] [Related]  

  • 4. It's not just theologians who are morally troubled.
    McSorley SJ
    Nature; 2005 Jan; 433(7024):355. PubMed ID: 15674263
    [No Abstract]   [Full Text] [Related]  

  • 5. Health research, data protection, and the public interest in notification.
    Taylor MJ
    Med Law Rev; 2011; 19(2):267-303. PubMed ID: 21531757
    [No Abstract]   [Full Text] [Related]  

  • 6. Disclosing industry relationships--toward an improved federal research policy.
    Campbell EG; Zinner DE
    N Engl J Med; 2010 Aug; 363(7):604-6. PubMed ID: 20647185
    [No Abstract]   [Full Text] [Related]  

  • 7. Researchers frustrated by Italian misconduct probe.
    Abbott A
    Nature; 2017 May; 545(7652):13-14. PubMed ID: 28470221
    [No Abstract]   [Full Text] [Related]  

  • 8. Agency under siege.
    Nature; 2005 Jul; 436(7049):304. PubMed ID: 16034377
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetically modified survival: red and green biotechnology in Israel.
    Prainsack B; Firestine O
    Sci Cult (Lond); 2005 Dec; 14(4):355-72. PubMed ID: 16619470
    [No Abstract]   [Full Text] [Related]  

  • 10. The appropriate limits of science in the formation of public policy.
    Condic ML; Condic SB
    Notre Dame J Law Ethics Public Policy; 2003; 17(1):157-79. PubMed ID: 14986651
    [No Abstract]   [Full Text] [Related]  

  • 11. The risks of exclusion.
    Nat Neurosci; 2003 Mar; 6(3):203. PubMed ID: 12601374
    [No Abstract]   [Full Text] [Related]  

  • 12. Paolo Macchiarini's academic afterlife in Russia ends.
    Astakhova A
    Science; 2017 May; 356(6339):672-673. PubMed ID: 28522475
    [No Abstract]   [Full Text] [Related]  

  • 13. Ecology: caught between shores.
    Hopkin M
    Nature; 2006 Mar; 440(7081):144-5. PubMed ID: 16525438
    [No Abstract]   [Full Text] [Related]  

  • 14. Institutional research and biomedical journals: Poor quality articles and honest researchers!
    Maisonneuve H; Slim K
    J Visc Surg; 2015 Nov; 152(5):275-8. PubMed ID: 26476677
    [No Abstract]   [Full Text] [Related]  

  • 15. Trust, but verify.
    Nature; 2009 Sep; 461(7262):315. PubMed ID: 19759574
    [No Abstract]   [Full Text] [Related]  

  • 16. The Role of the Virtuous Investigator in Protecting Human Research Subjects.
    Grady C; Fauci AS
    Perspect Biol Med; 2016; 59(1):122-31. PubMed ID: 27499489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical researchers' ancillary clinical care responsibilities.
    Belsky L; Richardson HS
    BMJ; 2004 Jun; 328(7454):1494-6. PubMed ID: 15205296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. US science policy: mission impossible?
    Brumfiel G
    Nature; 2004 Mar; 428(6980):250-1. PubMed ID: 15029165
    [No Abstract]   [Full Text] [Related]  

  • 19. How the US crackdown on bioterror is backfiring.
    MacKenzie D
    New Sci; 2003 Nov 8-14; 180(2420):6-8. PubMed ID: 14982094
    [No Abstract]   [Full Text] [Related]  

  • 20. Bioethics considerations for medical research in human archive tissues: the point of view of the researcher.
    Stanta G; Cescato A; Bonin S; Barbazza R
    Virchows Arch; 2008 Jul; 453(1):117-9. PubMed ID: 18551307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.